Glenmark Pharmaceuticals, Inc. 401(K) Plan — Form 5500 plan (Glenmark Pharmaceuticals, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Glenmark Pharmaceuticals, Inc. 401(K) Plan is a benefit plan reported by Glenmark Pharmaceuticals, Inc. under EIN 75-3102019 and plan number 001. The latest loaded filing year is 2023. The filing reports 663 participants and $21,387,844 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Glenmark Pharmaceuticals, Inc.
EIN
75-3102019
Plan number
001
Plan type
2
Location
Mahwah, NJ
Latest filing year
2023
Participants
663
End-of-year plan assets
$21,387,844

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023663H, C20241009160124NAL0009383747001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$21,387,844
Total liabilities (EOY)
$0
Net assets (EOY)
$21,387,844
Net assets (BOY)
$17,382,537

Income & contributions

Employer contributions
$996,047
Participant contributions
$2,071,974
Total contributions
$3,602,473
Total income / additions
$6,845,997

Expenses & distributions

Benefits paid
$2,718,108
Administrative expenses
$119,520
Total expenses
$2,840,690
Net increase / (decrease)
$4,005,307

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Empower Annuity Insurance CompanyRECORDKEEPER$48,599$02023
The Angell Pension Group IncCONTRACT ADMIN$35,380not reported in the loaded dataset2023
Lpl FinancialINVESTMENT ADVISOR$18,743not reported in the loaded dataset2023
Empower Advisory GroupINVESTMENT MANAGEMENT$18,343not reported in the loaded dataset2023

Related Form 5500 pages